App-Quantinova.ai

PREDICTORS OF MORTALITY AND GENDER DIFFERENCES IN TAKOTSUBO CARDIOMYOPATHY

Parasuram Krishnamoorthy - American College of Cardiology (ACC) , 2014

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Heart muscle disease

N/A

FRAGMENTED QRS PREDICTS CARDIAC EVENTS IN HYPERTROPHIC CARDIOMYOPATHY

Akihiro Nomura - American College of Cardiology (ACC) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Heart muscle disease

N/A

HEART FAILURE BURDEN IN CHILDREN AND ADULTS WITH FRIEDREICH ATAXIA

Carol Wittlieb-Weber - American College of Cardiology (ACC) , 2014

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Heart muscle disease

N/A

CHAGA- CARDIOMYOPATHY IS ASSOCIATED WITH A HIGHER INCIDENCE OF STROKE: A META ANALYSIS OF OBSERVATIONAL STUDIES

Francisco Y. Macedo - American College of Cardiology (ACC) , 2014

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Heart muscle disease

N/A

LEFT VENTRICULAR TONIC CONTRACTION FREQUENTLY PRECEDES DILATION IN CARDIOMYOPATHY OF DUCHENNE MUSCULAR DYSTROPHY

Jennifer Su - American College of Cardiology (ACC) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Heart muscle disease

N/A

VASCULOTROPIC PARVOVIRUS INFECTION IMPAIRS OUTCOME IN INFLAMMATORY CARDIOMYOPATHY

Uwe Kuehl - American College of Cardiology (ACC) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Heart muscle disease

folitixorin calcium

TWO-STAGED CLASSIFICATION BY LEFT VENTRICULAR EJECTION FRACTION FOLLOWED BY EXTENT OF LATE GADOLINIUM ENHANCEMENT IN CARDIAC MAGNETIC RESONANCE IS USEFUL FOR RISK STRATIFICATION IN HYPERTROPHIC CARDIOMYOPATHY

Akira Funada - American College of Cardiology (ACC) , 2014

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Heart muscle disease

N/A

LEFT VENTRICULAR HYPERTROPHY IN ATHLETES: THE GRAY-ZONE REVISITED

Stefano Caselli - American College of Cardiology (ACC) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Heart muscle disease

N/A

EARLY DETECTION OF IMPAIRED LEFT VENTRICULER FUNCTION IN FIRST DEGREE RELATIVES OF PATIENS WITH IDIOPATHIC DILATED CARDIOMYOPATHY: A STRAIN IMAGING STUDY

Mehmet Sefa Okten - American College of Cardiology (ACC) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Heart muscle disease

N/A

UNDERSTANDING THE PATHOPHYSIOLOGY OF APICAL BALLOONING SYNDROME, A STEP CLOSER!

Pranav Kansara - American College of Cardiology (ACC) , 2014

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Heart muscle disease

N/A

SEX DIFFERENCES IN HEART FAILURE HOSPITALIZATIONS IN PATIENTS WITH HYPERTROPHIC CARDIOMYOPATHY

Oludamilola Oluleye - American College of Cardiology (ACC) , 2014

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Heart muscle disease

N/A

PREVALENCE AND RESPONSE OF BLEEDING, INCLUDING TRANSFUSION DEPENDENT BLEEDING, TO INTERVENTION IN HYPERTROPHIC CARDIOMYOPATHY

Oral Waldo - American College of Cardiology (ACC) , 2014

Therapeutic Area

Disease

Drug/Treatment

Gastroenterology (GU)

Heart muscle disease

N/A

AFRICAN-AMERICANS WITH HYPERTROPHIC CARDIOMYOPATHY PRESENT MORE PRONOUNCED ECG ABNORMALITIES THAN CAUCASIANS

Lars Lindholm Sorensen - American College of Cardiology (ACC) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Heart muscle disease

N/A

WORSE FIBROSIS AND MICROVASCULAR ISCHEMIA ARE ASSOCIATED WITH HIGHER INCIDENCE OF ARRHYTHMIC EVENTS IN NON-OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY

Iraklis Pozios - American College of Cardiology (ACC) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Heart muscle disease

Mofezolac

HIGH RESOLUTION SYSTEMATIC DIGITAL HISTOLOGICAL QUANTIFICATION OF CARDIAC FIBROSIS AND ADIPOSE TISSUE IN PHOSPHOLAMBAN MUTATION ASSOCIATED CARDIOMYOPATHY

Johannes M.I.H. Gho - American College of Cardiology (ACC) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Heart muscle disease

N/A

IMPACT OF SURGICAL VENTRICULAR RECONSTRUCTION ON SPHERICITY INDEX IN PATIENTS WITH ISCHEMIC CARDIOMYOPATHY: FOLLOW-UP FROM STICH TRIAL

Jin-Oh Choi - American College of Cardiology (ACC) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Heart muscle disease

N/A

PREDICTORS OF SUPER-RESPONDERS TO CARDIAC RESYNCHRONIZATION THERAPY: RESULTS FROM CUBIC STUDY

Koji Tanaka - American College of Cardiology (ACC) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Heart muscle disease

Angiotensin II

PREDICTORS OF SURVIVAL IN PATIENTS UNDERGOING PERCUTANEOUS VENTRICULAR ASSIST DEVICE IMPLANTATION FOR CARDIOGENIC SHOCK

Devraj Sukul - American College of Cardiology (ACC) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Heart muscle disease

N/A

THE TOTAL ARTIFICIAL HEART: AN EFFECTIVE BRIDGE TO TRANSPLANTATION IN PATIENTS WITH ADVANCED HEART FAILURE

Swaminatha V. Gurudevan - American College of Cardiology (ACC) , 2014

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Heart muscle disease

N/A

CARDIOPROTECTIVE EFFECTS OF ECKLONIA CAVA POLYPHENOL AGAINST DOXORUBICIN-INDUCED CARDIOTOXICITY IN AN ANIMAL RAT MODEL WITH THE EVIDENCE OF ELECTRON MICROSCOPIC FINDING

Hyo-Suk Ahn - American College of Cardiology (ACC) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Heart muscle disease

Doxorubicin

Filters

3340 Abstracts